Samsara Bio Capital, LLC Eye Point Pharmaceuticals, Inc. Transaction History

Samsara Bio Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$3.03 - $9.0 $145,440 - $432,000	-48,000 Reduced 10.0%	432,000 $3.76 Million
Q1 2023 May 15, 2023	BUY	$2.28 - $5.04 $1.09 Million - $2.42 Million	480,000 New	480,000 $1.41 Million
Q4 2021 Feb 14, 2022	BUY	$10.18 - $18.4 $305,400 - $552,000	30,000 Added 6.67%	480,000 $5.88 Million
Q1 2021 May 18, 2021	BUY	$8.89 - $14.92 $4 Million - $6.71 Million	450,000 New	450,000 $4.57 Million

156

72.4M

187K

225K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $214M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samsara Bio Capital, LLC with notifications on news.